CLN5 Antikörper
-
- Target Alle CLN5 Antikörper anzeigen
- CLN5 (Ceroid-Lipofuscinosis, Neuronal 5 (CLN5))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CLN5 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein of human CLN5 (NP_006484.1).
- Isotyp
- IgG
- Top Product
- Discover our top product CLN5 Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:2000 IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- CLN5 (Ceroid-Lipofuscinosis, Neuronal 5 (CLN5))
- Andere Bezeichnung
- CLN5 (CLN5 Produkte)
- Synonyme
- NCL antikoerper, A730075N08Rik antikoerper, CLN5, intracellular trafficking protein antikoerper, ceroid-lipofuscinosis, neuronal 5 antikoerper, CLN5 antikoerper, Cln5 antikoerper
- Hintergrund
- This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.
- Molekulargewicht
-
Observed_MW: 41 kDa
Calculated_MW: 41 kDa
- Gen-ID
- 1203
- UniProt
- O75503
-